Wellcome Trust Sanger Institute

About Wellcome Trust Sanger Institute

Wellcome Trust Sanger Institute was established in 1992 as The Sanger Centre, named after double Nobel Laureate, Frederick Sanger. It was conceived as a large scale DNA sequencing centre to participate in the Human Genome Project, and went on to make the largest single contribution to the gold standard sequence of the human genome. From its inception the Institute established and has maintained a policy of data sharing, and does much of its research in collaboration.

Since 2000, the Institute expanded its mission to understand "the role of genetics in health and disease". The Institute now employs around 900 people and engages in four main areas of research: Human genetics, pathogen genetics, mouse and zebrafish genetics and bioinformatics.

Reviewers: 28

80th in United Kingdom

Reviews: 238

82nd in United Kingdom

Merit: 673

82nd in United Kingdom

Openness: 3.3%

22nd in United Kingdom

Journal Editors at Wellcome Trust Sanger Institute

Reviewers from Wellcome Trust Sanger Institute

  • Reviewer

    Francesco Iorio

    My area of expertise covers computational methods for pharmacogenomics and cancer functional genomics, drug discovery and re-positioning, machine learning techniques supporting gene regulatory network inference, and complex network theory. My Erdős number is 3.

  • Reviewer

    Jonas Demeulemeester

    Biochemist and Bioinformatician working as a postdoctoral research fellow at the Francis Crick Institute in London, in collaboration with the Wellcome Trust Sanger Institute in Cambridge, and the University of Leuven in Belgium. While my Ph.D. focused on retroviral integration targeting, drug discovery and chromatin readers, my current research interests lie in the field of cancer 'omics. I develop novel computational approaches and leverage large scale pan-cancer datasets as well as focused single-cell 'omics data to shed light onto tumor heterogeneity and evolution.

  • Reviewer

    Rebecca A Gladstone

    Working with 20,000 pneumococcal genomes to assess the impact of vaccination globally as part of the Global Pneumococcal Sequencing project @pneumowatch. Tweets as @becctococcus

  • Reviewer

    Gosia Trynka

    My group is studying the genetic predispositions for autoimmune diseases. We intersect immunology with genomic tools to understand the role of human variation in modulation of the immune system. By combining different levels of genomic information, including regulatory annotations of chromatin (e.g. histone modifications) and gene expression, we aim to understand how immune-associated genetic variants lead to autoimmune diseases.

  • Reviewer

    Samuel C Forster

    Sam's work combines microbiology, immunology and computational analysis to understand the functional role and community dynamics of the human microbiota in health and disease.

  • Reviewer
  • Reviewer

    Chrispin Chaguza, PhD

    I'm a Postdoctoral Fellow in Bioinformatics and Microbial Epidemiology in the Infection Genomics Programme at the Wellcome Sanger Institute in Cambridge, UK. My research uses whole genome sequencing to understand bacterial evolution, carriage and disease epidemiology, antimicrobial resistance and transmission.